These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31658304)

  • 1. Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies.
    Perelygina L; Chen MH; Suppiah S; Adebayo A; Abernathy E; Dorsey M; Bercovitch L; Paris K; White KP; Krol A; Dhossche J; Torshin IY; Saini N; Klimczak LJ; Gordenin DA; Zharkikh A; Plotkin S; Sullivan KE; Icenogle J
    PLoS Pathog; 2019 Oct; 15(10):e1008080. PubMed ID: 31658304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella virus-associated chronic inflammation in primary immunodeficiency diseases.
    Perelygina L; Icenogle J; Sullivan KE
    Curr Opin Allergy Clin Immunol; 2020 Dec; 20(6):574-581. PubMed ID: 33044342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rubella Virus-Associated Cutaneous Granulomatous Disease: a Unique Complication in Immune-Deficient Patients, Not Limited to DNA Repair Disorders.
    Buchbinder D; Hauck F; Albert MH; Rack A; Bakhtiar S; Shcherbina A; Deripapa E; Sullivan KE; Perelygina L; Eloit M; Neven B; Pérot P; Moshous D; Suarez F; Bodemer C; Bonilla FA; Vaz LE; Krol AL; Klein C; Seppanen M; Nugent DJ; Singh J; Ochs HD
    J Clin Immunol; 2019 Jan; 39(1):81-89. PubMed ID: 30607663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug Sensitivity of Vaccine-Derived Rubella Viruses and Quasispecies Evolution in Granulomatous Lesions of Two Ataxia-Telangiectasia Patients Treated with Nitazoxanide.
    Faisthalab R; Suppiah S; Dorsey M; Sullivan KE; Icenogle J; Perelygina L
    Pathogens; 2022 Mar; 11(3):. PubMed ID: 35335662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Live rubella virus vaccine long-term persistence as an antigenic trigger of cutaneous granulomas in patients with primary immunodeficiency.
    Bodemer C; Sauvage V; Mahlaoui N; Cheval J; Couderc T; Leclerc-Mercier S; Debré M; Pellier I; Gagnieur L; Fraitag S; Fischer A; Blanche S; Lecuit M; Eloit M
    Clin Microbiol Infect; 2014 Oct; 20(10):O656-63. PubMed ID: 24476349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. "Noninfectious" Cutaneous Granulomas in Primary Immunodeficiency Patients and Association With Rubella Virus Vaccine Strain.
    Murguia-Favela L; Hiebert J; Haber RM
    J Cutan Med Surg; 2019; 23(3):341-342. PubMed ID: 31070095
    [No Abstract]   [Full Text] [Related]  

  • 7. Detection of measles, mumps and rubella viruses by immuno-colorimetric assay and its application in focus reduction neutralization tests.
    Vaidya SR; Kumbhar NS; Bhide VS
    Microbiol Immunol; 2014 Dec; 58(12):666-74. PubMed ID: 25244651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A search for persistent measles, mumps, and rubella vaccine virus in children with human immunodeficiency virus type 1 infection.
    Frenkel LM; Nielsen K; Garakian A; Cherry JD
    Arch Pediatr Adolesc Med; 1994 Jan; 148(1):57-60. PubMed ID: 8143011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rubella virus replication by the broad-spectrum drug nitazoxanide in cell culture and in a patient with a primary immune deficiency.
    Perelygina L; Hautala T; Seppänen M; Adebayo A; Sullivan KE; Icenogle J
    Antiviral Res; 2017 Nov; 147():58-66. PubMed ID: 28974385
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of serum antibodies against measles, mumps and rubella after primary measles, mumps and rubella (MMR) vaccination in children.
    Rafiei Tabatabaei S; Esteghamati AR; Shiva F; Fallah F; Radmanesh R; Abdinia B; Shamshiri AR; Khairkhah M; Shekari Ebrahimabad H; Karimi A
    Arch Iran Med; 2013 Jan; 16(1):38-41. PubMed ID: 23273235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neutralization of Rubella Vaccine Virus and Immunodeficiency-Related Vaccine-Derived Rubella Viruses by Intravenous Immunoglobulins.
    Chen MH; Perelygina L; Hao L; Beard RS; Lackner C; Farcet MR; Karbiener M; Icenogle J; Kreil TR
    J Infect Dis; 2024 Oct; 230(4):e938-e942. PubMed ID: 38592952
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody persistence in children aged 6-7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection.
    Díaz Ortega JL; Castaneda D; Arellano Quintanilla DM; Martínez D; Trumbo SP; Fernández de Castro J
    Vaccine; 2017 May; 35(23):3116-3122. PubMed ID: 28457672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infectious cDNA clone of the RA27/3 vaccine strain of Rubella virus.
    Pugachev KV; Galinski MS; Frey TK
    Virology; 2000 Jul; 273(1):189-97. PubMed ID: 10891421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Persistent Rubella Virus With Idiopathic Skin Granulomas in Clinically Immunocompetent Adults.
    Wanat KA; Perelygina L; Chen MH; Hao L; Abernathy E; Bender NR; Shields BE; Wilson BD; Crosby D; Routes J; Samimi SS; Haun PL; Sokumbi O; Icenogle JP; Sullivan KE; Rosenbach M; Drolet BA
    JAMA Dermatol; 2022 Jun; 158(6):626-633. PubMed ID: 35338705
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Case report: Persistent shedding of a live vaccine-derived rubella virus in a young man with severe combined immunodeficiency and cutaneous granuloma.
    Bonner KE; Sukerman E; Liko J; Lanzieri TM; Sutton M; DeBess E; Leesman C; Icenogle J; Hao L; Chen MH; Faisthalab R; Leman RF; Cieslak PR; DeRavin SS; Perelygina L
    Front Immunol; 2022; 13():1075351. PubMed ID: 36569925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibody persistence after primary measles-mumps-rubella vaccine and response to a second dose given at four to six vs. eleven to thirteen years.
    Johnson CE; Kumar ML; Whitwell JK; Staehle BO; Rome LP; Dinakar C; Hurni W; Nalin DR
    Pediatr Infect Dis J; 1996 Aug; 15(8):687-92. PubMed ID: 8858673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in Establishment of Persistence of Vaccine and Wild Type Rubella Viruses in Fetal Endothelial Cells.
    Perelygina L; Adebayo A; Metcalfe M; Icenogle J
    PLoS One; 2015; 10(7):e0133267. PubMed ID: 26177032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of virological and serological methods for laboratory confirmation of rubella.
    Uchino K; Miyoshi T; Mori Y; Komase K; Okayama F; Shibata Y; Yoshida H; Numata T; Takeda M; Tanaka T
    J Clin Virol; 2020 Feb; 123():104257. PubMed ID: 31927348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Two-year antibody persistence in children vaccinated at 12-15 months with a measles-mumps-rubella virus vaccine without human serum albumin.
    Berry AA; Abu-Elyazeed R; Diaz-Perez C; Mufson MA; Harrison CJ; Leonardi M; Twiggs JD; Peltier C; Grogg S; Carbayo A; Shapiro S; Povey M; Baccarini C; Innis BL; Henry O
    Hum Vaccin Immunother; 2017 Jul; 13(7):1516-1522. PubMed ID: 28481690
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rubella vaccine-induced granulomas are a novel phenotype with incomplete penetrance of genetic defects in cytotoxicity.
    Groß M; Speckmann C; May A; Gajardo-Carrasco T; Wustrau K; Maier SL; Panning M; Huzly D; Agaimy A; Bryceson YT; Choo S; Chow CW; Dückers G; Fasth A; Fraitag S; Gräwe K; Haxelmans S; Holzinger D; Hudowenz O; Hübschen JM; Khurana C; Kienle K; Klifa R; Korn K; Kutzner H; Lämmermann T; Ledig S; Lipsker D; Meeths M; Naumann-Bartsch N; Rascon J; Schänzer A; Seidl M; Tesi B; Vauloup-Fellous C; Vollmer-Kary B; Warnatz K; Wehr C; Neven B; Vargas P; Sepulveda FE; Lehmberg K; Schmitt-Graeff A; Ehl S
    J Allergy Clin Immunol; 2022 Jan; 149(1):388-399.e4. PubMed ID: 34033843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.